Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC101060835 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
UBE2QL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
UFSP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SYNJ2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MREG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TET3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PHF14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GOLGA7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LY9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDS5A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HNRNPD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRKD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACTN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
F8A3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIAA1211 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MORC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TUG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on